Is poor response to recombinant erythropoietin associated with loss of T-lymphocyte CD28 expression and altered interleukin-10 production?
These findings suggest that patients responding poorly to Epo may show enhanced immune activation as manifest by changes in both T-cell function and phenotype.
The number of fetal cells in maternal blood is associated with certain cytokines and fetal gender.